Neoadjuvant ceritinib treatment achieved pathological complete response in patients with anaplastic lymphoma kinase positive stage IIIA-N2 non-small cell lung cancer

被引：0
|
作者：
Shen, Qian [1 ]
Gao, Qiqi [2 ]
Zhou, Jianying [1 ]
机构：
[1] Zhejiang Univ, Affiliated Hosp 1, Coll Med, Thorac Dis Ctr,Dept Resp Dis, Hangzhou 310003, Zhejiang, Peoples R China
[2] Zhejiang Univ, Affiliated Hosp 1, Coll Med, Dept Pathol, Hangzhou 310003, Zhejiang, Peoples R China
来源：
CHINESE MEDICAL JOURNAL | 2023年 / 136卷 / 07期
关键词：
D O I：
10.1097/CM9.0000000000002403
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：851 / 853
页数：3
相关论文
共 50 条
  • [1] Neoadjuvant ceritinib treatment achieved pathological complete response in patients with anaplastic lymphoma kinase positive stage IIIA-N2 non-small cell lung cancer
    Shen Qian
    Gao Qiqi
    Zhou Jianying
    中华医学杂志(英文版), 2023, 136 (07)
  • [2] Neoadjuvant chemotherapy for stage IIIA-N2 non-small cell lung cancer
    De Marinis, Filippo
    Gebbia, V.
    De Petris, L.
    ANNALS OF ONCOLOGY, 2005, 16 : 116 - 122
  • [3] Ceritinib for the treatment of patients with anaplastic lymphoma kinase (ALK)-positive metastatic non-small cell lung cancer
    Landi, Lorenza
    Cappuzzo, Federico
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2016, 9 (02) : 203 - 214
  • [4] Pathological complete response to neoadjuvant alectinib in unresectable anaplastic lymphoma kinase positive non-small cell lung cancer: A case report
    Wang, Lu-Ming
    Zhao, Peng
    Sun, Xu-Qi
    Yan, Feng
    Guo, Qian
    WORLD JOURNAL OF CLINICAL CASES, 2023, 11 (22) : 5322 - 5328
  • [5] Postoperative radiotherapy for pathological stage IIIA-N2 non-small cell lung cancer with positive surgical margins
    Yuan, Meng
    Men, Yu
    Kang, Jingjing
    Sun, Xin
    Zhao, Maoyuan
    Bao, Yongxing
    Yang, Xu
    Sun, Shuang
    Ma, Zeliang
    Wang, Jianyang
    Deng, Lei
    Wang, Wenqing
    Zhai, Yirui
    Liu, Wenyang
    Zhang, Tao
    Wang, Xin
    Bi, Nan
    Lv, Jima
    Liang, Jun
    Feng, Qinfu
    Chen, Dongfu
    Xiao, Zefen
    Zhou, Zongmei
    Wang, Luhua
    Hui, Zhouguang
    THORACIC CANCER, 2021, 12 (02) : 227 - 234
  • [6] FDA Approval: Ceritinib for the Treatment of Metastatic Anaplastic Lymphoma Kinase-Positive Non-Small Cell Lung Cancer
    Khozin, Sean
    Blumenthal, Gideon M.
    Zhang, Lijun
    Tang, Shenghui
    Brower, Margaret
    Fox, Emily
    Helms, Whitney
    Leong, Ruby
    Song, Pengfei
    Pan, Yuzhuo
    Liu, Qi
    Zhao, Ping
    Zhao, Hong
    Lu, Donghao
    Tang, Zhe
    Al Hakim, Ali
    Boyd, Karen
    Keegan, Patricia
    Justice, Robert
    Pazdur, Richard
    CLINICAL CANCER RESEARCH, 2015, 21 (11) : 2436 - 2439
  • [7] Neoadjuvant strategy for stage IIIA-N2 non-small cell lung cancer: chemoradiation or chemotherapy alone?
    Situ, Dongrong
    Lin, Yongbin
    JOURNAL OF THORACIC DISEASE, 2017, 9 (09) : 2746 - 2748
  • [8] Role of surgery for stage IIIA-N2 non-small cell lung cancer
    Yang, Fan
    Wang, Jun
    THORACIC CANCER, 2011, 2 (03) : 90 - 94
  • [9] Optimal Treatment of Stage IIIA-N2 Non-Small Cell Lung Cancer: A Neverending Story?
    Van Schil, Paul E.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (09) : 1338 - 1340
  • [10] Postoperative Radiation Therapy for Elderly Patients With Resected Pathological Stage IIIA-N2 Non-Small Cell Lung Cancer
    Hui, Z.
    Dai, H.
    Liang, J.
    Lv, J.
    Zhou, Z.
    Feng, Q.
    Xiao, Z.
    Chen, D.
    Zhang, H.
    Wang, L.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2013, 87 (02): : S523 - S523
12345